Glenmark Diltiazem Capsules Recall: Failed Dissolution Test Risk
Glenmark Pharmaceuticals recalls 120mg Diltiazem capsules with failed dissolution test. Do not use if expired or from specific lot. Contact for details.
Lower-risk recall
Failed Dissolution Specifications: Out of Specification (OOS) was reported in test of dissolution at the 12th month time point in long term stability study.
Contact the company
What happened, in plain English
Glenmark Pharmaceuticals is recalling 120mg Diltiazem Hydrochloride Extended-Release Capsules due to a dissolution test failure. This could affect medication effectiveness if the capsules don't release the drug properly over time. Read more at govinfonow.com/recall/32757-glenmark-diltiazem-capsules-recall-failed-dissolution-test-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/32757-glenmark-diltiazem-capsules-recall-failed-dissolution-test-risk · Updated September 23, 2026 · FDA enforcement record: FDA #D-0430-2024
Cite this page
“Glenmark Diltiazem Capsules Recall: Failed Dissolution Test Risk.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/32757-glenmark-diltiazem-capsules-recall-failed-dissolution-test-risk. Based on FDA recall #D-0430-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0430-2024%22&limit=1).
Why it’s dangerous
The capsules failed a dissolution test at 12 months, meaning they might not release the drug correctly over time. This could lead to inconsistent medication levels in the body, potentially affecting treatment effectiveness.
Who’s affected
People with prescriptions for this medication who received the recalled lot (17230304) from Glenmark. Those with specific medical conditions requiring precise dosing may be at higher risk.
How to tell if you have this one
Check for the lot number 17230304 on the bottle. The product is a 120mg Diltiazem capsule, 100-count bottle, manufactured in India with an expiration date of 12/31/2024.
- Brand
Glenmark- Category
Drug
What to do — step by step
Check Expiration Date
Verify the expiration date on the bottle; do not use if expired.
Contact Manufacturer
Reach out to Glenmark Pharmaceuticals for specific recall details and instructions.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the US” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 15 days after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
Similar recalls
Other Glenmark recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0430-2024 (March 26, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0430-2024 to see it in context.
- Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.